Wilkens, Finn M.
Ganter, Claudia
Kriegsmann, Katharina
Wilkens, Heinrike
Kahn, Nicolas
Goobie, Gillian C.
Ryerson, Christopher J.
Kreuter, Michael
Funding for this research was provided by:
Medizinische Fakultät Heidelberg der Universität Heidelberg
Article History
Received: 17 February 2022
Accepted: 12 April 2022
First Online: 27 April 2022
Declarations
:
: This work was part of an investigation in LAM with patient involvement an ethics approval was obtained accordingly (EK Number S -758/2020). The responsible ethics committee is Ethikkommission der Medizinischen Fakultät Heidelberg/Ethics Committee of the Medical Faculty Heidelberg, Alte Glockengießerei 11/1, 69115 Heidelberg. In this part of the project informed consent of patients was not applicable.
: Not applicable.
: FMW, CG, KK, NK and CR, MK reports no conflicts of interest related to this manuscript. HW received fees for lectures and/or consultations from Actelion, Bayer, Biotest, Boehringer, GSK, Janssen, Pfizer and Roche unrelated this manuscript. GCG receives support from the University of British Columbia Clinician Investigator Program, the Pulmonary Fibrosis Foundation Scholars Program, and Boehringer Ingelheim.